-
公开(公告)号:US12090119B2
公开(公告)日:2024-09-17
申请号:US16959545
申请日:2019-01-07
申请人: Pacifi Limited
发明人: Gareth Pearce
CPC分类号: A61J1/2027 , A61J1/065 , A61J1/2093 , B65B7/161 , B65B7/164 , B65B7/28 , B65B29/10
摘要: A method of packaging a two component composition into a dual vial (100), wherein the dual vial (100) comprises a single continuous piece of material arranged to provide both a first vial (110) and a second vial (120), the method comprising providing a second component of the composition into a volume, of the second vial (120), surrounding the first vial (110), providing a first component of the composition into a first vial (110), wherein the first vial (110) is nested within a second vial (120), and closing the first vial (110) and the second vial (120).
-
公开(公告)号:US20240277575A1
公开(公告)日:2024-08-22
申请号:US18693402
申请日:2022-09-19
CPC分类号: A61J1/2093 , A47J31/407 , A61J11/0075
摘要: A beverage ingredient mixing and dispensing assembly can include an adapter configured for attachment to a beverage container and can include a beverage ingredient receptacle having a piercing assembly configured to pierce a frangible seal of a beverage ingredient cartridge. The piercing assembly can pierce the seal and allow a beverage ingredient from within the cartridge to pass into the beverage container for mixing with a liquid and thereby forming a mixed beverage. The beverage ingredient receptacle can be removable. A plurality of different seized beverage ingredient receptacles can be removably attached to the adapter. A retainer member can be placed over a top end of a beverage ingredient cartridge positioned in the beverage ingredient receptacle.
-
公开(公告)号:US11974966B2
公开(公告)日:2024-05-07
申请号:US16631030
申请日:2018-07-12
发明人: David Filiberto Schuck , Karl Hans Cazzini , Yuanpang Samuel Ding , Ying-Cheng Lo , Grant Anthony Bomgaars , Thomas Edward Dudar , Mark Edward Pasmore , Bernd Krause , Michael Joseph Sadowski , Anastasios Hristakos , Joseph Vincent Ranalletta
CPC分类号: A61J1/1456 , A61J1/10 , A61J1/1475 , A61J1/2024 , A61J1/2093 , B01D63/0241
摘要: A medical product includes a bladder, a filtration device, and a sterile product concentrate. The bladder has a perimeter seal and defining a sterile chamber. The filtration device includes a stem and a filter membrane disposed in line with the stem. The stem extends through the perimeter seal and has an inlet end accessible from outside of the perimeter seal and an outlet end in fluid communication with the sterile chamber. The filter membrane can have a nominal pore size in a range of approximately 0.1 μm to approximately 0.5 μm, wherein the filter membrane is shaped as a hollow fiber with a wall and pores residing in the wall of the fiber. The sterile product concentrate is disposed in the sterile chamber and adapted to be reconstituted by the introduction of a pharmaceutical fluid into the chamber through the filtration device.
-
公开(公告)号:US11903946B2
公开(公告)日:2024-02-20
申请号:US17494866
申请日:2021-10-06
申请人: CEVA SANTE ANIMALE
IPC分类号: A61K31/53 , A61J1/20 , A61K33/26 , A61P33/02 , A61K9/08 , A61K47/02 , A61K9/10 , A61K45/06 , A61K9/00
CPC分类号: A61K31/53 , A61J1/2093 , A61K9/0095 , A61K9/08 , A61K9/10 , A61K33/26 , A61K45/06 , A61K47/02 , A61P33/02 , A61K31/53 , A61K2300/00 , A61K33/26 , A61K2300/00
摘要: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
-
公开(公告)号:US20230347059A1
公开(公告)日:2023-11-02
申请号:US18095321
申请日:2023-01-10
发明人: John Scott Keadle
CPC分类号: A61M5/2448 , A61J1/2093 , A61M5/19 , A61J1/2041 , A61M5/31596 , A61M5/284 , A61M2005/2462 , A61M2005/287
摘要: Various implementations include a mixing vial system. The system includes a hypodermic syringe and a mixing vial. The mixing vial includes a vessel, a stopper, and a dislodgeable plug. The vessel includes an open end, a closed end, and a side wall. A hollow interior chamber is defined by the side wall and the closed end. The open end defines a neck. The stopper includes an open proximal end, a closed distal end, and a stopper side wall. The closed distal end and the stopper side wall define a hollow interior chamber. The stopper is positioned in a sealing relationship within the neck. The dislodgeable plug is positioned in and sealing the open proximal end of the stopper. The closed distal end of the stopper is penetrable by a needle of the hypodermic syringe to dislodge the dislodgeable plug to effect mixing of contents of the stopper and the vessel.
-
公开(公告)号:US11744776B2
公开(公告)日:2023-09-05
申请号:US18054252
申请日:2022-11-10
IPC分类号: A61J1/20 , A61J1/14 , A61K31/4184 , A61K31/706 , A61K45/06 , A61M5/14 , B65D77/04 , B65D81/32 , A61J1/10 , B65D75/58 , A61K9/19 , C08L25/08 , F26B5/06 , F26B25/06
CPC分类号: A61J1/2024 , A61J1/10 , A61J1/1468 , A61J1/1475 , A61J1/2089 , A61J1/2093 , A61K31/4184 , A61K31/706 , A61K45/06 , A61M5/1407 , A61M5/1411 , A61M5/1413 , B65D75/5883 , B65D77/04 , B65D81/3261 , B65D81/3266 , B65D81/3272 , A61J1/1481 , A61K9/19 , A61M2205/3606 , C08L25/08 , F26B5/06 , F26B25/063
摘要: A method of preparing a pharmaceutical product in a single multiple chamber flexible bag. A pharmaceutical product is introduced in a liquid state into a first chamber of the flexible bag through a first port. The pharmaceutical product is lyophilized within the first chamber of the flexible bag to provide a lyophilized pharmaceutical product. The flexible bag has a second chamber and the first chamber and the second chamber are separated by a breakable seal. The second chamber further includes a reconstituting solution for reconstituting the lyophilized pharmaceutical product in the first chamber. A user may apply pressure to the flexible bag to break the seal and mix the lyophilized pharmaceutical product and the reconstituting solution to order to administer the pharmaceutical product to a patient.
-
公开(公告)号:US20190038509A1
公开(公告)日:2019-02-07
申请号:US16158631
申请日:2018-10-12
CPC分类号: A61J1/2024 , A61J1/10 , A61J1/2093 , A61M5/1407 , A61M5/1411 , A61M5/1413 , A61M2205/3606 , B65D77/04 , B65D81/3266 , B65D81/3272 , F26B5/06 , F26B25/063
摘要: A method of preparing a pharmaceutical product in a single multiple chamber flexible bag. A pharmaceutical product is introduced in a liquid state into a first chamber of the flexible bag through a first port. The pharmaceutical product is lyophilized within the first chamber of the flexible bag to provide a lyophilized pharmaceutical product. The flexible bag has a second chamber and the first chamber and the second chamber are separated by a breakable seal. The second chamber further includes a reconstituting solution for reconstituting the lyophilized pharmaceutical product in the first chamber. A user may apply pressure to the flexible bag to break the seal and mix the lyophilized pharmaceutical product and the reconstituting solution to order to administer the pharmaceutical product to a patient.
-
公开(公告)号:US20180236162A1
公开(公告)日:2018-08-23
申请号:US15958941
申请日:2018-04-20
CPC分类号: A61M5/1407 , A61J1/20 , A61J1/202 , A61J1/2093 , A61M5/1408 , A61M5/1409 , A61M5/1413 , A61M5/142 , A61M5/14232 , A61M5/14244 , A61M5/16827 , A61M5/16881 , A61M2205/8206 , B65D55/06 , B65D55/066
摘要: A unified dispenser for holding, mixing, and dispensing a drug includes a housing holding a diluent reservoir, a drug reservoir, and a tubing set connecting and defining a fluid communication path therebetween. A first occlusion is at the diluent reservoir, and a second occlusion is at the drug reservoir. In a storage state of the dispenser, the first and second occlusions are entirely encased within the housing and occlude the fluid communication path. First and second pull assemblies extend outside the housing. The first and second pull assemblies are coupled to the first and second occlusions, respectively, so that removal of the first and second pull assemblies removes the first and second occlusions and joins the diluent reservoir to the drug reservoir in fluid communication through the tubing set, thereby arranging the dispenser from the storage state to a use state.
-
公开(公告)号:US09987194B2
公开(公告)日:2018-06-05
申请号:US14835757
申请日:2015-08-26
申请人: Muffin Incorporated
发明人: William J. Havel , Neal E. Fearnot , Peter S. McKinnis , Richard B. Sisken , Charles Leland Baxter
IPC分类号: B65D75/42 , B65D75/44 , B31B70/00 , A61J1/14 , A61J1/10 , A61J1/20 , B65B51/26 , B29C65/00 , B29C65/02 , B65D77/00 , B65D75/58 , B29C65/08 , B29C65/10 , B29C65/14 , B29C65/16 , B29C65/48 , B29C65/04 , B29L31/00
CPC分类号: A61J1/1406 , A61J1/10 , A61J1/1468 , A61J1/2093 , B29C65/02 , B29C65/04 , B29C65/08 , B29C65/10 , B29C65/14 , B29C65/16 , B29C65/48 , B29C65/4895 , B29C66/1122 , B29C66/344 , B29C66/3452 , B29C66/43121 , B29C66/71 , B29C66/7212 , B29C66/73921 , B29C66/8266 , B29C66/8322 , B29L2031/7148 , B31B70/00 , B65B51/26 , B65D75/42 , B65D75/44 , B65D75/5883 , B29K2023/083 , B29K2307/04 , B29K2023/06 , B29K2023/12 , B29K2027/06 , B29K2075/00
摘要: Described in one aspect is a multi-cell or multi-chambered container for sealing various materials such as therapeutic or diagnostic agents, animal or human tissue, tissue samples, specimens, blood, genetic material, or any other material. The container includes seals formed by folding the wall of the elongate body transverse to the interior of the elongate body and maintaining the folded wall portions adjacent one another or joining them together. In another aspect, the container disclosed may be made according to a method involving creating multiple seals at various locations along the elongate body thus creating sealed voids or cells between the seals within the elongate body.
-
公开(公告)号:US20180110680A1
公开(公告)日:2018-04-26
申请号:US15568463
申请日:2016-04-22
发明人: Ian B. Copland , Ashley Reavis , Emily Butts , Marisa Casola , Nihir Patel
CPC分类号: A61J1/2027 , A61F9/0008 , A61F9/0026 , A61J1/067 , A61J1/1475 , A61J1/202 , A61J1/2093 , A61K9/19
摘要: Described are single-use dispensing devices with a dry chamber containing lyophilized material, a wet chamber containing reconstituting solution, a breaking chamber positioned between and attached to the dry chamber and a first end of the wet chamber. The breaking chamber includes a leak-proof frangible seal that prevent mixing of the lyophilized material and the reconstituting solution until the frangible seal is broken.
-
-
-
-
-
-
-
-
-